Event dossier

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

Innovent Biologics rose as much as 10%, after entering a strategic global licensing and collaboration agreement with Pfizer to develop oncology medicines.

0 reports0 sourcesMay 29, 2026, 3:10 AM
FilterEvent feed
Clustered coverageAll sources
Coverage timeline0
Coverage timeline

Coverage timeline

Ranked reports inside the event cluster. Open any publisher link to read the original coverage.

No linked coverage has been stored for this event yet.
Related events

Related events

Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.

El Psy Congroo